Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
about
mTOR Regulation of Lymphoid Cells in Immunity to PathogensHaploidentical Transplantation in Children with Acute Leukemia: The Unresolved IssuesRas family of small GTPases in immunity and inflammationImpact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation conditionIdentification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejectionLow incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivoImmunoregulatory functions of mTOR inhibition.Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksUltrasound-promoted synthesis and immunosuppressive activity of novel quinazoline derivatives.Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinomamTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infectionNK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging.Changes in natural killer cell subsets in pediatric liver transplant recipientsTeratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat.The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.STAT4-associated natural killer cell tolerance following liver transplantation.Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment.The role of natural killer cells in human solid organ and tissue transplantation.NK cells after transplantation: friend or foe.Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Regulation of innate immune cell function by mTOR.Synthesis and biological evaluation of pseudolaric acid B derivatives as potential immunosuppressive agents.Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cellsKIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.The role of alloresponsive Ly49+ NK cells in rat islet allograft failure in the presence and absence of cytomegalovirus.The Role of NK Cells in Pig-to-Human Xenotransplantation.Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT.
P2860
Q26744649-5C8F33B8-67B8-48E2-99E2-DBB8DA410DBDQ26750671-F241B5B4-58EF-481E-97D5-F59B849099F0Q27008372-63B8025F-B85B-403B-BD4B-18A01CF9420EQ28488660-8D47275A-4AD1-44D8-8D7E-22046D95899AQ28570224-662F06FD-8A4C-4396-A098-BBEC66E7A88EQ30252205-622E5D16-892A-403F-B7C7-2B73C83366EBQ33725633-18BAA740-B5FF-451D-B153-C857B206AA9BQ33761278-0B707893-E059-497C-85BA-FA594853B1E1Q34316147-E1FD96A2-A131-4B69-9DC0-DD5FE3625CA7Q34379063-2872CA7A-7734-4997-AA97-CD2C5C551E1BQ34586486-E43AE57D-D50F-42E8-BCE1-B5D79DC774B2Q35050505-BC1EE1CA-EABB-4984-95B9-B67E0273F424Q35202828-79DCDE45-3C4E-4D13-9362-479F504C0B49Q35683731-2B91A5DD-C231-44DF-AC91-163404686527Q35837364-A55236A2-97BA-40F0-A34A-8C0A33B0F037Q36499442-C72A7C23-2110-4080-A1B4-8D44F00A1F48Q36730484-2137A458-29E2-4BC2-B709-32951A680F8FQ37012579-711AA7C0-89BA-45C8-BFBA-2F140C915F3DQ37617088-01047096-5333-4819-B3EC-1DD7A9CFE2BCQ37842326-BEB991A1-DCC0-4F98-9C3A-618A69EE0A27Q37853788-63B09062-9176-4C6C-BB94-14990D93EB24Q38187574-4CD7761A-A40C-4BC1-B4AA-81FBEE2674C3Q38221107-FA94945E-815D-453A-B1A6-DDAC7E013EFCQ38592317-FA0F2ECB-F073-40BE-B921-BF4784BB9D7BQ39015941-BA2BF766-D814-4A45-B55E-34BB115027E4Q41912497-94C999BC-20E3-4979-864B-332D4C404464Q42172253-78F210AA-63D5-4D5F-AC25-F9C73DE19819Q42206830-C8CD6A1D-F59A-4D52-A21C-468BE3EC5217Q42283002-FE69398B-65FB-4BFC-9273-1ED5C41D6F83Q48093746-7E68DBB9-EF64-4EE7-8A8B-9E80305AE6D7Q48121295-65579FF3-61A1-476A-BE3E-D986DC1728B0Q54609253-0EAE4B8C-EB29-4D9E-9FAB-0476841ABEE6
P2860
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@ast
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@en
type
label
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@ast
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@en
prefLabel
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@ast
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
@en
P2093
P2860
P1433
P1476
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function
@en
P2093
Masato Fujiki
Olivia M Martinez
Sheri M Krams
P2860
P304
P356
10.1097/01.TP.0000296817.28053.7B
P50
P577
2008-01-01T00:00:00Z